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Differential Expression of Adhesion Molecules within the
Human Thymus
JULIE NAIMA REZA and MARY A. RITTER
Department of Immunology, Royal Postgraduate Medical School, Du Cane Road, London W12 ONN, U.K
Development of a diverse, MHC-restricted yet self-tolerant T-cell repertoire occurs within
the thymus, and requires contact between developing T cells and their stromal microenvi-
ronment. Such interactions are likely to depend on the combinatorial effect of specific
adhesion molecules. As a preliminary step to determining their role in T-cell development,
we have studied the distribution of LFA-1/ICAM-1, CD2/LFA-3, VLA-4/VCAM-1, and
HECA 452-antigen/E-Selectin ligand pairs on frozen sections of human thymus. Using two
color-immunohistochemistry, and a variety of cell-lineage markers that reveal the nature of
the cells on which these adhesion molecules are located, we find a differential distribution
of adhesion molecules, with some being shared by both endothelial and epithelial cells. We
also identify the VCAM-l-positive subpopulation as cortical macrophages. The relevance of
these findings to thymopoiesis is discussed.
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INTRODUCTION
A fully functional immune system requires the
generation of a diverse T-cell repertoire, which is
both major histocompatibility-(MHC) restricted and
self-tolerant. This development occurs in the thy-
mus (reviewed by Boyd and Hugo, 1991; Ritter and
Crispe, 1992; Boyd et al., 1993; and Ritter and Boyd,
1993), where bone marrow-derived pluripotent
stem cells first enter the thymus and subsequently
interact with stromal cells. The developing thymo-
cytes change phenotypes and also undergo positive
and negative selection, rendering them self-MHC-
restricted (Sprent et al., 1975; Jenkinson et al., 1985;
Kappler et al., 1987; Marrack et al., 1988) and
self-tolerant (Lo and Sprent, 1986; Marrack et al.,
1988; Berg et al., 1989), respectively. Thus, interac-
tions between thymocytes and stromal cells,
whether cell-cell or via soluble molecules, must
provide signals for the migration, proliferation, mat-
uration, and selection of T cells, as well as signals for
maintaining the structural integrity of the thymic
microenvironment. Details about such interactions
are unclear, but it is likely tha adhesion molecules
are involved.
*Corresponding author.
Adhesion molecules can be divided into several
groups (reviewed by Albelda and Buck, 1990;
Springer, 1990; and Pigott and Power, 1993): (a) the
Immunoglobulin superfamily (e.g., CD2, Vascular
Cell Adhesion Molecule [VCAM]-1, Intercellular Cell
Adhesion Molecule [ICAM]-I, and Leucocyte Func-
tion Related Antigen [LFA]-3), which are involved in
cell-cell adhesion; (b) Integrins (e.g., Very Late An-
tigen [VLA]-4 and LFA-1) involved in cell-cell and
cell-substratum adhesion; (c) Selectins/LEC-CAMS
(cell adhesion molecules with several lectin-like do-
mains) (e.g., Endothelial-Selectin [E-Selectin]) that
mediate interaction of leucocytes with endothelial
cells; (d) Cadherins, involved in homophilic cell-cell
adhesion; and (e) homing receptors that target lym-
phocytes to specific lymphoid tissues. Other mole-
cules, such as carbohydrate moieties of glycoproteins
(e.g., sialyl Lewis X [sLeX] related structures) or con-
stituents of the extracellular matrix (e.g., fibronectin
[FN]) may also be involved in adhesion.
In the periphery, different functions and distribu-
tions can be attributed to various (endothelial) adhe-
sion molecules, (reviewed by Shimizu et al., 1992),
and it is likely that such diversity is also found in the
thymus. Two major cell lineages that thymocytes
encounter within the thymus are the endothelium
(described as the "gatekeeper" regulating lympho-
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cyte interactions with tissue) and the epithelium.
Therefore, in this paper, by concentrating on adhe-
sion molecules found on peripheral endothelium or
epithelium (see Table 1), whose ligands may be
found on T cells, we attempt to elucidate the role of
adhesion molecules during T-cell development
within the thymus. Using immunohistochemical
techniques on cryostat sections, we studied the
expression of the receptor-ligand pairs LFA-1/
ICAM-1 or ICAM-2; CD2/LFA-3; VLA-4/VCAM-1
or fibronectin; and the antigen recognized by HECA
452 (HECA 452-Ag)/E-Selectin on human pediatric
thymus. We report a differential distribution of
adhesion molecules on stromal cells (epithelium,
endothelium, and macrophages) within the thymus,
and identify the VCAM-1 positive cell subpopula-
tion as cortical macrophages.
RESULTS
Single immunoperoxidase staining of various adhe-
sion molecules and their ligands on frozen human
thymus sections can be seen in Figs. 1-3. Results of
double immunoenzyme staining versus "lineage-
specific" markers are summarized in Table 2 and
double staining of VCAM-1 versus "lineage-
specific" markers can be seen in Fig. 4.
LFA-1, ICAM-1, and ICAM-2
The anti-LFA-1 antibody used (Table 3) recognizes
CD 1 la, the alpha chain of LFA- 1. Our results show
that this antibody stains thymocytes throughout the
cortex and medulla, with medullary thymocytes
staining more strongly (Figs. la and le). Epithelial
cells appear LFA-l-negative (however, when lym-
phocyte staining is strong, it is difficult to exclude
very low levels of staining on nonlymphoid cells).
Anti-ICAM-1, on the other hand, reveals a predom-
inantly medullary, nonlymphoid pattern of staining
(Figs. lb and lf). Double staining experiments show
that ICAM-1 can be found at relatively high levels
on a subpopulation of medullary and cortical epi-
thelial cells, some macrophages, as well as blood
vessels. The two different anti-IC/XM-1 antibodies
used, 6.5B5 (not shown) and 8.486, gave similar
staining patterns, although 8.486 showed stronger
staining, especially of epithelial cells (Fig. lc). This
difference may be attributable to a difference in
affinity of the antibodies. ICAM-2 was found to be
negative in the thymus (Fig. l d).
CD2 and LFA-3
Anti-CD2 stains thymocytes, with epithelial and
endothelial cells being CD2-negative (Fig. 2a). The
TABLE
Characteristics and Peripheral Distribution of the Adhesion Molecules Studied
T-cell molecule Mwt(kD) Family Distribution
(peripheral)
Counterreceptor Mwt (kD) Family Distribution
(peripheral)
LFA-1 (OL2; 180/95 INT Lymphocytes,
CD1la/CD18) neutrophils,
myelomonocytes









LFA-3 (CD58) 50-77 INT Various cell
types
CD2 (LFA-2; Tll; 47-58 IG T cells NK cells
Tp50, Leu 5)
VLA-4 ((41; 160/130 INT Resting lympho-
CD49d/CD29; cytes, mono-
LPAM-2 [mouse]) cytes, melanoma
cells





HECA 452 Ag CHO Some T cells and E-Selectin 115
(sLeX-related an- myelomonocytic (ELAM- 1;
tigens) cells LECAM-2;
CD62E)
Abbreviations: Mwt --Molecular weight; INT integrin; IG immunoglobulin; CHO carbohydrate; and SEL selectin.
SEL Activated
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TABLE 2
Lineages of Cells Expressing Various Adhesion Molecules as Determined by Double Immunoenzyme Labeling of Human Pediatric
Thymus Sections
Cell subpopulation IcAM-1 ICAII-2 IFA3 E-Slectin VCAI-I
Cortical epithelium + + sp + + +
Medullary epithelium + + + sp + + (+)
Medullary blood vessels + + + )/-
Blood vessels in C-M junction + + + + + )/-
Cortical blood vessels + + + + )/-
Blood vessels in septae + + + + )/-
Medullary macrophages + )sp + )sp
Cortical macrophages + )sp + )sp + + +
Medullary lymphocytes + )/+
Cortical lymphocytes + )/+
As by distribution tissue sections. weak (+) very weak moderate strong negative C-M corticomedullary sp subpopulation.
TABLE 3


















Antibodies were obtained either monoclonal preparations polysera.
Dako, High Wycombe, U.K. bGenerous gifts of D. Haskard, R.P.M.S., London, U.K.
Generous gift of W. Makgoba, R.P.M.S., London, U.K. ATCC HB 205, ATCC,
Rockville, Maryland eSerotec, Oxford, U.K.
results obtained by Watt et al., 1992). It does not
appear to be expressed on other cell lineages (Fig.
3a)--a pattern completely different to that given by
two of its ligands, VCAM-1 and FN (Figs. 3b and 3c,
respectively). Several different anti-VCAM-1 anti-
bodies were used (1Gll, 1E5, 6D9, 3B10, and
1.4C3), some of which recognize nonoverlapping
epitopes. These all gave a similar staining pattern,
strongly staining "patches" in the cortex (e.g. Fig. 3d
showing staining obtained with 3B10), whilst
weakly staining some epithelial and endothelial cells.
Double immunoenzyme staining of anti-VCAM-1
(1Gll) versus anti-macrophage (anti-CD68) reveal
these "patches" as cortical macrophages (Fig. 4a).
Medullary macrophages are VCAM-l-negative (Fig.
4b). Double immunoenzyme staining of anti-
VCAM-1 (1Gll) versus anti-laminin (used as a
marker for blood vessels and basement membrane)
shows that VCAM-l-positive cells often appear
closely associated with blood vessels (Fig. 4c).
DISCUSSION
T-cell development occurs under the influence of
stromal elements in the thymus, and probably in-
volves adhesion molecules. Little is known about
the role of such molecules within the thymus,
(reviewed by Patel and Haynes, 1993), although a
degree of circumstantial evidence supports their
involvement in thymopoiesis.
In many cases, adhesion molecule expression or
binding affinity can be increased following cytokine
stimulation or cell activation. Further, one adhesion
"receptor" may have multiple ligands, or multiple
adhesion receptors may exist for one particular
ligand. Such potential for upregulation of avidity
and expression, the existence of multiple adhesion
pathways, and the expression of different adhesion
molecules leading to different intracellular events (as
suggested by Albelda and Buck, 1990) provide a
variety of ways in which cells may interact with one
another to give a range of results, and is likely to be
of importance in lymphocyte-stromal interactions in
the thymus.
In this paper, we have studied the expression of
various adhesion molecules on stromal cells, and
compared expression to that of their ligands in situ
using immunohistochemical techniques. It should
be noted that some antigens lose their antigenicity
during tissue preparation or may be present at levels
too low to be detected by the techniques used in this
paper, yet may still be of biological significance.
LFA-1, ICAM-1, and ICAM-2
Our studies show that LFA-1 appears to be ex-
pressed on all thymocytes, and at slightly higher-
levels in the medulla. This would agree with
experiments where LFA-1 is expressed on memory62 J.N. REZA and M.A. RITTER
extent on corticomedullary blood vessels, suggesting
that it is important in leucocyte traffic. It was noted
that neutrophils were commonly found near these
E-Selectin positive cells, implying that E-Selectin
may be involved in neutrophil recruitment. In the
thymus, it is possible that leucocytes produce IL-1
(known to increase E-Selectin synthesis in periph-
eral endothelium), and thus increase leucocyte in-
teraction with thymic endothelium. E-Selectin may
function in initiating leucocyte-endothelium cell ad-
hesion, and hence it may be important in recruit-
ment of T-cell precursors to various thymic
subcompartments. If this was the case, one would
expect the ligand forE-Selectin to be found on
leucocytes/thymocytes. However, in our experi-
ments, expression of the "assumed" ligand (HECA
452-Ag) seems to be localized mainly to blood
vessels in the corticomedullary junction, although
some staining can be seen on extrathymic blood
vessels, neutrophils, and on cells in the medulla.
These latter were not identified in these experi-
ments, but two color flow cytometry will indicate if
some are T-cell precursors, although Picker et al.
(1990) have found that 99% of thymocytes are
HECA 452-negative.
Thus, our findings support the involvement of
E-Selectin and HECA 452-Ag in leucocyte traffic/
endothelial cell interaction rather than in thymocyte
development itself.
and macrophages via VLA-4 (expressed at higher
levels on cortical thymocytes than medullary thy-
mocytes), consistent with data obtained by Kyewski
et al., (1982). Moreover, VCAM-1 expression is
modulated by the T-cell-produced cytokine IL-4,
suggesting that developing T cells may influence
their stromal microenvironment (Ritter and Boyd,
1993). We also observed close association of VCAM-
1 macrophages with cortical capillaries, although
the developmental significance of this is unclear.
In this paper, we have shown that there is a
differential distribution of adhesion molecules
within different thymic areas, and that some adhe-
sion molecules such as ICAM-1 are shared by
different lineages, whereas others, such as E-
Selectin are exclusively found on thymic blood
vessels. We have also shown that even where
lymphocyte ligands (e.g., LFA-1, CD2, and VLA-4)
have a broad distribution on thymocytes, their
corresponding adhesion ligands may show more
selective distributions, suggesting that different
interactions/functions occur in different regions of
the thymus. Overall, our results suggest that adhe-
sion molecules are likely to be important in T-cell
development, although functional experiments are
needed to clarify their role.
MATERIALS AND METHODS
VLA-4, VCAM-1, and FN
VLA-4 can bind VCAM-1, or the extracellular ma-
trix molecule FN.
Our experiments show that VLA-4 is expressed
on thymocytes (at slightly higher levels in the
cortex, which is consistent with flow cytometric data
[Watt et al., 1992)]. However, its two ligands show
totally different patterns of expression. FN forms
part of the extracellular matrix, especially in the
medulla as noted in other mammals. This con-
served nature of thymic FN distribution is thought
to imply a functional role for extracellular matrix
(Utsumi et al., 1991; Savino et al., 1993). We show
that VCAM-1 is mainly expressed on cortical mac-
rophages. This suggests that VLA-4 interacts with
different ligands at different stages of thymic devel-
opment. The distribution of VLA-4 is greater than
the combined distribution of its ligands. This may
imply that there is control of specific interactions by
modification of VLA-4 affinity. VCAM-1 may be
involved in an interaction between early thymocytes
Thymus Sections
Thymus samples were obtained from patients (aged
0-4 years) undergoing cardiac surgery. Blocks of
tissue were frozen in liquid nitrogen, and 6m
cryostat sections cut. Sections were fixed in acetone
and stored at -20C. Experiments were repeated on
several different thymuses.
Antibodies
All antibodies were titrated before use and subse-
quently used at the appropriate dilution.
Primary antibodies Anti-adhesion molecule anti-
bodies used are outlined in Table 3. "Lineage-
specific" markers used included rabbit anti-keratin
(Dako, High Wycombe, U.K.) to identify epithelial
cells, rabbit anti-laminin (Serotec, Oxford, U.K.) to
identify basement membrane associated with cap-
sule and blood vessels, and mouse anti-CD68
(Dako) to identify macrophages.ADHESION MOLECULES IN HUMAN THYMUS 63
Secondary antibodies Peroxidase conjugated rabbit
anti-mouse Ig (Dako); peroxidase conjugated swine
anti-rabbit Ig (Dako); .peroxidase conjugated rabbit
anti-rat Ig (Dako); alkaline-phosphatase conjugated
swine anti-rabbit Ig (Dako); and alkaline-
phosphatase conjugated rabbit anti-mouse Ig
(Dako). These were all prepared and preincubated
with 5% normal human serum/TBS for 15-30 min
to block binding to endogenous Ig in sections.
Imrnunohistochemistry
Single immunoenzyme labeling This labeling deter-
mines distribution of adhesion molecules. Sections
were incubated in primary antibodies against adhe-
sion molecules, followed by peroxidase conjugated
secondary antibody. The reaction was developed
using 0.1% 3,3’-diaminobenzidine tetrahydrochlo-
ride (DAB) (Sigma, Poole, U.K.) as chromogen sub-
strate with 0.015% H202. Sections were
counterstained with haematoxylin and mounted in
Kaiser’s gelatin-based mountant.
Double immunoenzyme labeling This labeling deter-
mines lineage of cells stained with anti-ICAM-1,
-VCAM-1, -E-Selectin, and-LFA-3. Sections were
incubated with these antibodies, followed by perox-
idase conjugated secondary antibody, and develop-
ment of reaction with DAB/H202 substrate.
Sections were then incubated with lineage-specific
antibodies (anti-keratin, anti-laminin, and anti-
macrophage, CD68), followed by alkaline-
phosphatase conjugated secondary antibody, and
the reaction developed using 0.1% fast blue BB salt
(Sigma) with 0.02% napthol AS-MX phosphate
(Sigma), 2% dimethyl formamide (BDH, Poole,
U.K.), and 0.2% levamisole (Sigma). (Use of immu-
noenzymatic techniques avoids problems with cross
reactivity; antibodies that are used in the peroxidase
step lose their antigenicity and binding capacity
once this step is developed, and thus do not inter-
fere with the subsequent alkaline phosphatase step.)
No counterstaining was carried out. Slides were
mounted as before. Sections were photographed
using Kodacolor Gold ASA 200 film.
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